Cited 24 time in
Gender-specific differences in PPARγ regulation of follicular helper T cell responses with estrogen
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Park, Hong-Jai | - |
| dc.contributor.author | Park, Hyeon-Soo | - |
| dc.contributor.author | Lee, Jae-Ung | - |
| dc.contributor.author | Bothwell, Alfred L. M. | - |
| dc.contributor.author | Choi, Je-Min | - |
| dc.date.accessioned | 2021-08-02T16:52:20Z | - |
| dc.date.available | 2021-08-02T16:52:20Z | - |
| dc.date.issued | 2016-06 | - |
| dc.identifier.issn | 2045-2322 | - |
| dc.identifier.issn | 2045-2322 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/23023 | - |
| dc.description.abstract | Peroxisome proliferator-activated receptor gamma (PPARγ), a master regulator of adipocyte differentiation, has recently been connected with effector T cells, though its role is still not clear. Here, we investigated the roles of PPARγ in follicular helper T (TFH) cell responses regarding gender specificity. NP-OVA immunization in female but not male CD4-PPARγKO mice induced higher proportions of TFH cells and germinal center (GC) B cells following immunization than were seen in wild type mice. Treatment with the PPARγ agonist pioglitazone significantly reduced TFH cell responses in female mice while pioglitazone and estradiol (E2) co-treatment ameliorated TFH cells and GC responses in male mice. E2 treatment significantly enhanced PPARγ expression in male T cells, while T cell activation in the estrus but not in the diestrus stage of the menstrual cycle of females was inhibited by pioglitazone, suggesting that an estrogen-sufficient environment is important for PPARγ-mediated T cell regulation. These results demonstrate gender-based differences in sensitivities of PPARγ in TFH responses. These findings suggest that appropriate function of PPARγ is required in the regulation of female GC responses and that therapeutic strategies for autoimmune diseases using PPARγ agonists need to be tailored accordingly. | - |
| dc.format.extent | 9 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Nature Publishing Group | - |
| dc.title | Gender-specific differences in PPARγ regulation of follicular helper T cell responses with estrogen | - |
| dc.type | Article | - |
| dc.publisher.location | 영국 | - |
| dc.identifier.doi | 10.1038/srep28495 | - |
| dc.identifier.scopusid | 2-s2.0-84975717638 | - |
| dc.identifier.wosid | 000378319800001 | - |
| dc.identifier.bibliographicCitation | Scientific Reports, v.6, pp 1 - 9 | - |
| dc.citation.title | Scientific Reports | - |
| dc.citation.volume | 6 | - |
| dc.citation.startPage | 1 | - |
| dc.citation.endPage | 9 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
| dc.relation.journalWebOfScienceCategory | Multidisciplinary Sciences | - |
| dc.subject.keywordPlus | ACTIVATED RECEPTOR-GAMMA | - |
| dc.subject.keywordPlus | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | - |
| dc.subject.keywordPlus | ADIPOCYTE DIFFERENTIATION | - |
| dc.subject.keywordPlus | GENE-EXPRESSION | - |
| dc.subject.keywordPlus | SEX-DIFFERENCES | - |
| dc.subject.keywordPlus | FATTY-ACIDS | - |
| dc.subject.keywordPlus | THERAPY | - |
| dc.subject.keywordPlus | IMMUNOREGULATION | - |
| dc.subject.keywordPlus | PIOGLITAZONE | - |
| dc.subject.keywordPlus | ENHANCEMENT | - |
| dc.identifier.url | https://www.nature.com/articles/srep28495 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
